Načítá se...
Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
BACKGROUND: Factor VIIa (recombinant) has an off-label use to control life-threatening bleeding that is refractory to other measures and was shown to decrease transfusion requirements. OBJECTIVE: The primary objective of this study was to assess the safety and effectiveness of factor VIIa (recombina...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353622/ https://ncbi.nlm.nih.gov/pubmed/22623836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0973-6247.95044 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|